Why the study?
Do specific interventions (isoproterenol, disopyramide, slow heart rate) induce TU abnormalities and MAP humps in patients with Torsades de Pointes?
Do specific interventions (isoproterenol, disopyramide, slow heart rate) induce TU abnormalities and MAP humps in patients with Torsades de Pointes?
Specific interventions such as isoproterenol and disopyramide can induce TU abnormalities and MAP humps in susceptible patients with Torsades de Pointes, indicating a hypersensitive reaction.
MAP humps induced by isoproterenol or disopyramide may mark TDP susceptibility; leaves open diagnostic utility pending prospective validation.
TU abnormalities could be induced by the specific interventions in the majority of the patients with TDP in chronic stage: isoproterenol in congenital long QT patients, disopyramide in Ia-related TDP patients, and slow heart rate in bradycardia-related TDP patients. 2. Humps in MAP could be recorded in all patients with congenital long QT syndrome by isoproterenol, in half of the patients with Ia-related TDP by disopyramide, but in none of the control patients by these agents. 3. The results suggested that TU abnormalities and the occurrence of hump in MAP were hypersensitive reactions. 4. The results also suggested that specific intervention was not enough for the appearance of marked TU abnormalities in some TDP patients, especially in Ia-related TDP patients. Additional aggravating factors were probably required for marked TU abnormalities and the occurrence of TDP in these patients.
No takes yet. Share an insight, caveat, or question.
Ohe et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: